0001209191-18-041906.txt : 20180706
0001209191-18-041906.hdr.sgml : 20180706
20180706180632
ACCESSION NUMBER: 0001209191-18-041906
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180703
FILED AS OF DATE: 20180706
DATE AS OF CHANGE: 20180706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SLATTERY JOSEPH P
CENTRAL INDEX KEY: 0001246530
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 18943123
MAIL ADDRESS:
STREET 1: C/O TRANSENTERIX, INC.
STREET 2: 635 DAVIS DRIVE, SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANSENTERIX INC.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-765-8400
MAIL ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: SafeStitch Medical, Inc.
DATE OF NAME CHANGE: 20080211
FORMER COMPANY:
FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC
DATE OF NAME CHANGE: 19930328
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-03
0
0000876378
TRANSENTERIX INC.
TRXC
0001246530
SLATTERY JOSEPH P
C/O TRANSENTERIX, INC.
635 DAVIS DRIVE, SUITE 300
MORRISVILLE
NC
27560
0
1
0
0
EVP and CFO
Common Stock
2018-07-03
4
M
0
166667
0.00
A
166667
D
Common Stock
2018-07-03
4
F
0
58334
3.84
D
108333
D
Common Stock
2018-07-03
4
S
0
2491
4.01
D
105842
D
Common Stock
2018-07-03
4
S
0
11883
4.00
D
93959
D
Common Stock
2018-07-05
4
S
0
37337
4.00
D
56622
D
Common Stock
25000
I
By IRA
Restricted Stock Units
2018-07-03
4
M
0
166667
0.00
D
Common Stock
166667
333333
D
This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares.
The transaction occurred pursuant to a written trading plan dated November 29, 2017, meeting the requirements of Rule 10b5-1(c).
Following the sales on July 3, 2018 and July 5, 2018, the reporting person continues to beneficially own 81,622 shares of the company's common stock. The reporting person also holds stock options to acquire 1,886,821 shares of common stock, of which approximately 27% are vested, and restricted stock units representing an additional 595,777 shares of common stock subject to forfeiture restrictions.
Each restricted stock unit represents the right to receive one share of the Registrant's common stock.
Forfeiture restrictions will lapse as to 1/3rd of the Restricted Stock Units on each of the first three anniversaries of the date of grant, as long as the Reporting Person remains in the employ of the Registrant. The lapse of forfeiture restrictions may accelerate on certain events as set forth in an employment agreement or the Incentive Plan.
/s/ Joshusa Weingard, as Attorney-in-Fact for Joseph Slattery
2018-07-06